• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT261414
Device Problem No Apparent Adverse Event (3189)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/24/2017
Event Type  Injury  
Manufacturer Narrative
(b)(4).Medical devices: patient medications include toprol and zafera.Ct images dated (b)(6) 2017 were received by gore from the facility and an imaging evaluation was performed.A type ia endoleak was verified from the proximal edge of the excluder® device.The anatomical angle of the infrarenal neck was measured at 59 degrees, which falls within recommendations of the gore® excluder® aaa endoprosthesis instructions for use (ifu).There was approximately 2 cm of length from the lowest renal artery to the proximal end of the endoprosthesis.No other endoleaks were observed.The inferior mesenteric artery was noted as patent and filling retrograde, but not filling the aneurysm sac.A review of the manufacturing records for the device verified that the lot met all pre-release specifications.Per ifu, adverse events that may occur and/or require intervention include but are not limited to endoleak.
 
Event Description
On (b)(6) 2014, the patient was implanted with three gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.On (b)(6) 2017, computed tomography (ct) scan reportedly revealed a proximal type i endoleak contributing to aneurysm enlargement (amount unknown).A lack of proximal device apposition to the vessel wall was also reported.On (b)(6) 2018, the patient underwent a re-intervention procedure whereby two excluder® aortic extender components were implanted proximally to treat the type i endoleak.The endoleak was resolved and the patient tolerated the procedure.
 
Manufacturer Narrative
Original date of implant was (b)(6) 2014.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL PHOENIX 2 B/P
32470 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
damon jackson
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key7169477
MDR Text Key96577419
Report Number3007284313-2018-00006
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/16/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/05/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/30/2017
Device Catalogue NumberRLT261414
Device Lot Number12611659
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/08/2014
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
Patient Weight80
-
-